Article Details
Retrieved on: 2024-02-28 13:03:09
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Corbus Pharmaceuticals Holdings, Inc.'s appointment of Dr. Dominic Smethurst as CMO. Dr. Smethurst's expertise will advance the company's biopharma pipeline, including a Nectin-targeting drug, within the oncology space involving firms like Roche and Amgen.
Article found on: finance.yahoo.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here